As the Market's overheating, (Nasdaq: LABD) the S&P Biotech Bear 3x hits all-time lows, and Brexit fears loom. LABD gives a nice potential entry for biotech traders looking for protection the next … [Read more...] about Why I’m Bullish On Brexit: Part deux
Nasdaq: EYPT) Eyepoint Pharmaceuticals #focus by follow_the_money on TradingView.com This past week Eyepoint Pharmaceuticals filed form 4's three days in a row. Interestingly, this week Eyepoint … [Read more...] about MS Swing Move #Focused
According to Elliot wave theory and Fibonacci ratio, GALT is showing bullish signs of reversal. GALT ran up from $3.19 to $6.06. It has since pulled back to ~$4.19 (also, .786 retracement) #KEY … [Read more...] about (Nasdaq: GALT) Galectin Therapeutics, Reversal?
Last week Verastem presented additional Copiktra data at the Leerinks Health Care Conference followed by a Q&A session by analysts. The webcast can be accessed here. In this article, I discuss the … [Read more...] about Can Verastem Shake the DownTrend?
Lymphoma Patients Want and Need A Better Quality Of Life As a Lymphoma survivor, I can say unequivocally, that TO MUCH TIME is spent in the chemo wing, away from our families. Therefore, as … [Read more...] about (Nasdaq: VSTM) Verastem, Better Quality of Life? A Patients Perspective
Swing Thesis This swing-trade for Conatus Pharmaceuticals, (Nasdaq: CNAT) is based on Technical Analysis (which aligns with some key dates) and a fundamental component. With regards to technical … [Read more...] about Technically Swinging CNAT